Demonising Justin Gatlin
13th September 2015
The Union Cycliste Internationale (UCI) announces that French rider Rémy Di Gregorio was notified of an Adverse Analytical Finding (AAF) of darbepoetin (dEPO)* in a sample collected on 8 March 2018 during Paris-Nice. This intelligence-led doping control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling, with the collaboration of the Agence Française de Lutte contre le Dopage (AFLD) and the Office central de lutte contre les atteintes à l’environnement et à la santé publique (OCLAESP).
The rider has the right to request and attend the analysis of the B sample. In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair. At this stage of the procedure, the UCI will not comment any further on this matter.
* dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.
• This media release was published by the international cycling union (UCI) on 11 April 2018. Click here for the original.
Former cyclist Lance Armstrong has paid the US government US$5 million to settle a lawsuit...
Constant Omari Selemani, a member of the FIFA Council, senior figure in African football and...